SHMT1 and neoplasm: However, several studies have indicated that blocking mitochondrial 1C flux with SHMT2 inhibitors cannot abolish the neoplasia of hepatocellular cancer cells absolutely, whereas targeting mitochondrial and cytosolic 1C flux with dual SHMT1/2 inhibitors can restrain the formation of transplanted tumors completely.